{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:07:57Z","timestamp":1793138877548,"version":"4.5.0"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Promotion of Cancer Research and Therapeutic Evolution","award":["JP23ama221325h0001"],"award-info":[{"award-number":["JP23ama221325h0001"]}]},{"name":"Research Program for Hepatitis","award":["JP24fk0210158h0001"],"award-info":[{"award-number":["JP24fk0210158h0001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumor microenvironment (TME) is a complex landscape where metabolic interactions significantly dictate antitumor immunity. Immune evasion in cancer is typically discussed in terms of inhibitory receptors and ligands, suppressive cytokines, defective antigen presentation, and metabolic competition. However, recent evidence reveals that intercellular mitochondrial transfer adds a new mechanism of immune evasion in the TME. The mitochondrial fitness of T cells is central to sustained effector function, memory formation, and responsiveness to immune-checkpoint blockade. Tumor cells can act as pathogenic mitochondrial donors, transferring functional or dysfunctional mitochondria to neighboring T cells via tunneling nanotubes and extracellular vesicles. This process involves a mitophagy imbalance that leads to the homoplasmic replacement of endogenous mitochondria, thereby driving T-cell senescence, impairing memory formation and long-term antitumor function, and ultimately weakening cancer immunosurveillance. Overall, mitochondrial transfer should be considered a new part of the tumor immune evasion framework. It also provides new therapeutic opportunities for improving cancer immunotherapy.<\/jats:p>","DOI":"10.1093\/intimm\/dxag027","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:45:59Z","timestamp":1779882359000},"page":"603-609","source":"Crossref","is-referenced-by-count":2,"title":["Mitochondrial transfer-driven immune evasion in the tumor microenvironment"],"prefix":"10.1093","volume":"38","author":[{"given":"Li","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Tumor Microenvironment, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , Okayama 700-8558 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-0164","authenticated-orcid":false,"given":"Yosuke","family":"Togashi","sequence":"additional","affiliation":[{"name":"Department of Tumor Microenvironment, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , Okayama 700-8558 ,","place":["Japan"]},{"name":"Advanced Research Field, Institute for Emerging Medical Innovation, Okayama University Hospital , Okayama 700-8558 ,","place":["Japan"]},{"name":"Department of Respiratory Medicine, Okayama University Hospital , Okayama 700-8558 ,","place":["Japan"]},{"name":"Faculty of Medicine, Kindai University , Osaka 589-8511 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2026100105520665100_dxag027-B1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"2026100105520665100_dxag027-B2","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1111\/cas.15497","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"113","author":"Nagasaki","year":"2022","journal-title":"Cancer Sci"},{"key":"2026100105520665100_dxag027-B3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"2026100105520665100_dxag027-B4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"2026100105520665100_dxag027-B5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"2026100105520665100_dxag027-B6","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1172\/JCI80004","article-title":"From mice to humans: developments in cancer immunoediting","volume":"125","author":"Teng","year":"2015","journal-title":"J Clin Invest"},{"key":"2026100105520665100_dxag027-B7","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"2026100105520665100_dxag027-B8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"2026100105520665100_dxag027-B9","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"2026100105520665100_dxag027-B10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2026100105520665100_dxag027-B11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2026100105520665100_dxag027-B12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"2026100105520665100_dxag027-B13","doi-asserted-by":"publisher","first-page":"104216","DOI":"10.1016\/j.ebiom.2022.104216","article-title":"Obstacles for T-lymphocytes in the tumour microenvironment: therapeutic challenges, advances and opportunities beyond immune checkpoint","volume":"83","author":"Verma","year":"2022","journal-title":"EBioMedicine"},{"key":"2026100105520665100_dxag027-B14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molmed.2017.11.005","article-title":"Metabolic control of CD8+ T cell fate decisions and antitumor immunity","volume":"24","author":"Zhang","year":"2018","journal-title":"Trends Mol Med"},{"key":"2026100105520665100_dxag027-B15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","article-title":"The multifaceted contributions of mitochondria to cellular metabolism","volume":"20","author":"Spinelli","year":"2018","journal-title":"Nat Cell Biol"},{"key":"2026100105520665100_dxag027-B16","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","article-title":"Mitochondria in health, disease, and aging","volume":"103","author":"Harrington","year":"2023","journal-title":"Physiol Rev"},{"key":"2026100105520665100_dxag027-B17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ni.3704","article-title":"Mitochondria are the powerhouses of immunity","volume":"18","author":"Mills","year":"2017","journal-title":"Nat Immunol"},{"key":"2026100105520665100_dxag027-B18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41577-019-0140-9","article-title":"Metabolic interventions in the immune response to cancer","volume":"19","author":"O\u2019Sullivan","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2026100105520665100_dxag027-B19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8+ T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2026100105520665100_dxag027-B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2025.10.004","article-title":"Mitochondrial transfer at the crossroads of cancer, stromal, and immune cells","author":"Ishino","year":"2026","journal-title":"Trends Cell Biol"},{"key":"2026100105520665100_dxag027-B21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/cas.70342","article-title":"Mitochondrial transfer in the tumor microenvironment","volume":"117","author":"Omae","year":"2026","journal-title":"Cancer Sci"},{"key":"2026100105520665100_dxag027-B22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","article-title":"The power and potential of mitochondria transfer","volume":"623","author":"Borcherding","year":"2023","journal-title":"Nature"},{"key":"2026100105520665100_dxag027-B23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41577-025-01223-9","article-title":"Targeting organelle function in T cells for cancer immunotherapy","volume":"26","author":"Baldwin","year":"2026","journal-title":"Nat Rev Immunol"},{"key":"2026100105520665100_dxag027-B24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s42255-024-01200-x","article-title":"Recommendations for mitochondria transfer and transplantation nomenclature and characterization","volume":"7","author":"Brestoff","year":"2025","journal-title":"Nat Metab"},{"key":"2026100105520665100_dxag027-B25","doi-asserted-by":"publisher","first-page":"e202211044","DOI":"10.1083\/jcb.202211044","article-title":"Mitochondria on the move: horizontal mitochondrial transfer in disease and health","volume":"222","author":"Dong","year":"2023","journal-title":"J Cell Biol"},{"key":"2026100105520665100_dxag027-B26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ccell.2025.03.002","article-title":"Horizontal mitochondrial transfer in cancer biology: potential clinical relevance","volume":"43","author":"Berridge","year":"2025","journal-title":"Cancer Cell"},{"key":"2026100105520665100_dxag027-B27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"2026100105520665100_dxag027-B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41565-021-01006-y","article-title":"Cancer cells hijack T-cell mitochondria","volume":"17","author":"Baldwin","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"2026100105520665100_dxag027-B29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cmet.2025.12.014","article-title":"Mitochondrial transfer from immune to tumor cells enables lymph node metastasis","volume":"38","author":"Terasaki","year":"2026","journal-title":"Cell Metab"},{"key":"2026100105520665100_dxag027-B30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"2026100105520665100_dxag027-B31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","article-title":"Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion","volume":"21","author":"Yu","year":"2020","journal-title":"Nat Immunol"},{"key":"2026100105520665100_dxag027-B32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"2026100105520665100_dxag027-B33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"2026100105520665100_dxag027-B34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"2026100105520665100_dxag027-B35","doi-asserted-by":"publisher","first-page":"e93411","DOI":"10.1172\/jci.insight.93411","article-title":"Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma","volume":"2","author":"Siska","year":"2017","journal-title":"JCI Insight"},{"key":"2026100105520665100_dxag027-B36","doi-asserted-by":"publisher","first-page":"843242","DOI":"10.3389\/fimmu.2022.843242","article-title":"The role of metabolic dysfunction in T-cell exhaustion during chronic viral infection","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"2026100105520665100_dxag027-B37","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"2026100105520665100_dxag027-B38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","article-title":"T cells with dysfunctional mitochondria induce multimorbidity and premature senescence","volume":"368","author":"Desd\u00edn-Mic\u00f3","year":"2020","journal-title":"Science"},{"key":"2026100105520665100_dxag027-B39","doi-asserted-by":"publisher","first-page":"a012641","DOI":"10.1101\/cshperspect.a012641","article-title":"The maintenance of mitochondrial DNA integrity\u2014critical analysis and update","volume":"5","author":"Alexeyev","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026100105520665100_dxag027-B40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41568-021-00358-w","article-title":"Mitochondrial DNA variation and cancer","volume":"21","author":"Kopinski","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"2026100105520665100_dxag027-B41","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.trecan.2022.08.001","article-title":"Mitochondrial DNA is a major source of driver mutations in cancer","volume":"8","author":"Kim","year":"2022","journal-title":"Trends Cancer"},{"key":"2026100105520665100_dxag027-B42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41588-019-0557-x","article-title":"Comprehensive molecular characterization of mitochondrial genomes in human cancers","volume":"52","author":"Yuan","year":"2020","journal-title":"Nat Genet"},{"key":"2026100105520665100_dxag027-B43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1126\/science.1156906","article-title":"ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis","volume":"320","author":"Ishikawa","year":"2008","journal-title":"Science"},{"key":"2026100105520665100_dxag027-B44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","article-title":"Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells","volume":"17","author":"Saha","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"2026100105520665100_dxag027-B45","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1038\/s41598-019-44346-5","article-title":"Stress-induced tunneling nanotubes support treatment adaptation in prostate cancer","volume":"9","author":"Kretschmer","year":"2019","journal-title":"Sci Rep"},{"key":"2026100105520665100_dxag027-B46","doi-asserted-by":"publisher","first-page":"43150","DOI":"10.18632\/oncotarget.9504","article-title":"Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells","volume":"7","author":"Desir","year":"2016","journal-title":"Oncotarget"},{"key":"2026100105520665100_dxag027-B47","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/cdd.2010.147","article-title":"Tunneling-nanotube development in astrocytes depends on p53 activation","volume":"18","author":"Wang","year":"2011","journal-title":"Cell Death Differ"},{"key":"2026100105520665100_dxag027-B48","doi-asserted-by":"publisher","first-page":"e29537","DOI":"10.1371\/journal.pone.0029537","article-title":"Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses","volume":"6","author":"Ranzinger","year":"2011","journal-title":"PLoS One"},{"key":"2026100105520665100_dxag027-B49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","article-title":"Extracellular vesicles and nanoparticles: emerging complexities","volume":"33","author":"Jeppesen","year":"2023","journal-title":"Trends Cell Biol"},{"key":"2026100105520665100_dxag027-B50","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"2026100105520665100_dxag027-B51","doi-asserted-by":"publisher","first-page":"e12320","DOI":"10.1002\/jev2.12320","article-title":"MitoEVs: a new player in multiple disease pathology and treatment","volume":"12","author":"Zhou","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"2026100105520665100_dxag027-B52","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2014-05-573543","article-title":"Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation","volume":"124","author":"Boudreau","year":"2014","journal-title":"Blood"},{"key":"2026100105520665100_dxag027-B53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"2026100105520665100_dxag027-B54","doi-asserted-by":"publisher","first-page":"e104705","DOI":"10.15252\/embj.2020104705","article-title":"Molecular mechanisms and physiological functions of mitophagy","volume":"40","author":"Onishi","year":"2021","journal-title":"EMBO J"},{"key":"2026100105520665100_dxag027-B55","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature13418","article-title":"The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy","volume":"510","author":"Bingol","year":"2014","journal-title":"Nature"},{"key":"2026100105520665100_dxag027-B56","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb3097","article-title":"USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria","volume":"17","author":"Cunningham","year":"2015","journal-title":"Nat Cell Biol"},{"key":"2026100105520665100_dxag027-B57","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/1878-0261.70142","article-title":"Imperial strategy of cancer cells through mitochondrial transfer","volume":"19","author":"Ishino","year":"2025","journal-title":"Mol Oncol"},{"key":"2026100105520665100_dxag027-B58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"2026100105520665100_dxag027-B59","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"2026100105520665100_dxag027-B60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+ PD-1+ CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"2026100105520665100_dxag027-B61","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","article-title":"Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy","volume":"187","author":"Baldwin","year":"2024","journal-title":"Cell"},{"key":"2026100105520665100_dxag027-B62","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s43018-025-01038-6","article-title":"MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiation","volume":"6","author":"Cangkrama","year":"2025","journal-title":"Nat Cancer"},{"key":"2026100105520665100_dxag027-B63","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2026100105520665100_dxag027-B64","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1038\/s41467-024-53908-9","article-title":"Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy","volume":"15","author":"Forsthuber","year":"2024","journal-title":"Nat Commun"},{"key":"2026100105520665100_dxag027-B65","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer-associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat Commun"},{"key":"2026100105520665100_dxag027-B66","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov"},{"key":"2026100105520665100_dxag027-B67","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1038\/s41467-025-63659-w","article-title":"AEBP1 drives fibroblast-mediated T cell dysfunction in tumors","volume":"16","author":"Wang","year":"2025","journal-title":"Nat Commun"},{"key":"2026100105520665100_dxag027-B68","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41586-025-08633-8","article-title":"Programs, origins and immunomodulatory functions of myeloid cells in glioma","volume":"640","author":"Miller","year":"2025","journal-title":"Nature"},{"key":"2026100105520665100_dxag027-B69","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s42003-023-04525-7","article-title":"Tissue-resident macrophages are major tumor-associated macrophage resources, contributing to early TNBC development, recurrence, and metastases","volume":"6","author":"Hirano","year":"2023","journal-title":"Commun Biol"},{"key":"2026100105520665100_dxag027-B70","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/0008-5472.CAN-24-2274","article-title":"Myeloid cells induce infiltration and activation of B cells and CD4+ T follicular helper cells to sensitize brain metastases to combination immunotherapy","volume":"85","author":"Ninomiya","year":"2025","journal-title":"Cancer Res"},{"key":"2026100105520665100_dxag027-B71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"2026100105520665100_dxag027-B72","doi-asserted-by":"publisher","first-page":"E761","DOI":"10.1073\/pnas.1620433114","article-title":"Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity","volume":"114","author":"Chamoto","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026100105520665100_dxag027-B73","doi-asserted-by":"publisher","first-page":"eabq0021","DOI":"10.1126\/scitranslmed.abq0021","article-title":"Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer","volume":"14","author":"Tanaka","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026100105520665100_dxag027-B74","doi-asserted-by":"publisher","first-page":"eabj3510","DOI":"10.1126\/science.abj3510","article-title":"Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice","volume":"378","author":"Al-Habsi","year":"2022","journal-title":"Science"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intimm\/advance-article-pdf\/doi\/10.1093\/intimm\/dxag027\/68430198\/dxag027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/38\/10\/603\/68430198\/dxag027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/38\/10\/603\/68430198\/dxag027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:52:25Z","timestamp":1790848345000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article\/38\/10\/603\/8697894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":74,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5,29]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxag027","relation":{},"ISSN":["1460-2377"],"issn-type":[{"value":"1460-2377","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,5,29]]}}}